Medtronic Evolut™ TAVR platform outperforms surgery with sustained valve performance for low-risk patients at four yearsPRNewsWire • 10/24/23
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrestPRNewsWire • 10/23/23